Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000696941 | SCV000825525 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2024-09-26 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000696941 | SCV000895958 | uncertain significance | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002334326 | SCV002638021 | uncertain significance | Inborn genetic diseases | 2024-05-02 | criteria provided, single submitter | clinical testing | The c.4828C>T (p.L1610F) alteration is located in exon 10 (coding exon 8) of the SETX gene. This alteration results from a C to T substitution at nucleotide position 4828, causing the leucine (L) at amino acid position 1610 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Athena Diagnostics | RCV002473117 | SCV002771066 | uncertain significance | not provided | 2022-06-27 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV002473117 | SCV005190539 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005240484 | SCV005884881 | uncertain significance | not specified | 2024-12-23 | criteria provided, single submitter | clinical testing | Variant summary: SETX c.4828C>T (p.Leu1610Phe) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4.8e-05 in 251418 control chromosomes, predominantly at a frequency of 0.00011 within the Non-Finnish European subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in SETX causing Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 (4.8e-05 vs 0.0012), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.4828C>T in individuals affected with Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 574888). Based on the evidence outlined above, the variant was classified as uncertain significance. |